TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novo Genetix AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
631
|
284
|
273 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
32
|
-30
|
-25 |
| EBITDA |
32
|
-30
|
-25 |
| Total assets |
171
|
143
|
198 |
| Current assets |
171
|
143
|
198 |
| Current liabilities |
20
|
17
|
28 |
| Equity capital |
130
|
101
|
131 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.0%
|
70.6%
|
66.2% |
| Turnover per employee |
631
|
284
|
273 |
| Profit as a percentage of turnover |
5.1%
|
-10.6%
|
-9.2% |
| Return on assets (ROA) |
18.7%
|
-21.0%
|
-12.6% |
| Current ratio |
855.0%
|
841.2%
|
707.1% |
| Return on equity (ROE) |
24.6%
|
-29.7%
|
-19.1% |
| Change turnover |
357
|
10
|
-65 |
| Change turnover % |
130%
|
4%
|
-19% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.